Amanote Research
Register
Sign In
Adding Acute Treatments for Patients on Triptans: Results of the American Migraine Prevalence & Prevention (AMPP) Study
Journal of Headache and Pain
- Italy
doi 10.1186/1129-2377-1-s14-p214
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Neurology
Anesthesiology
Pain Medicine
Date
January 1, 2013
Authors
RB Lipton
D Serrano
S Kori
C Cunanan
AN Manack
ML Reed
DC Buse
Publisher
Springer Science and Business Media LLC
Related search
Major Life Events, Stress Appraisal, and Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
Migraine Diagnosis and Treatment: Results From the American Migraine Study II
Headache
Neurology
Lasmiditan for the Acute Treatment of Migraine: Subgroup Analyses by Prior Response to Triptans
Cephalalgia
Medicine
Neurology
Progress in Clinical Neurosciences a Systematic Review of the Use of Triptans in Acute Migraine
Canadian Journal of Neurological Sciences
Medicine
Neurology
Acute Migraine Treatment - Information for Patients
Canadian Journal of Neurological Sciences
Medicine
Neurology
What Inpatient Treatments Do We Have for Acute Intractable Migraine?
Cleveland Clinic Journal of Medicine
Medicine
Up to Date on the Use of Triptans for Child and Adolescent Migraine: State of the Art
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
Prevalence of Obesity in Patients Suffering From Migraine
International Journal of Research in Medical Sciences
Prevalence of Migraine.
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery